Free Daily Podcast Summary
AI in Medicine - curated summaries making complex issues easy to understand: Daily Summaries Delivered
by Mike Rawson
AI in Medicine - Smart Summaries is a daily podcast for clinicians, health-system leaders and medtech, pharma and digital-health teams.Each episode unpacks one important public document on artificial intelligence in healthcare, such as FDA, EMA, MHRA, WHO or NHS guidance, OECD and World Economic Forum reports, or an open-access peer-reviewed review, in a clear 15 to 20 minute conversation.Topics include clinical AI and decision support, medical imaging and radiology AI, large language models (LLMs) and generative AI in clinical practice, AI-enabled medical devices and their regulation, the EU AI Act, drug discovery and clinical trials, digital health and wearables, health-system adoption, patient safety, bias and liability.The source of every episode is linked in the show notes, and full transcripts are at ai-in-medicine-podcast.vercel.app. The hosts' voices are AI-generated. For information only, not medical advice.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- Today12 min
Company Spotlight: DeepHealth ProstateAI - Standardizing Prostate MRI Detection
This episode unpacks the FDA 510(k) summary for DeepHealth ProstateAI, a radiological software device developed by Quantib BV. We explore how the deep learning tool assists physicians in detecting and characterizing prostate cancer lesions, examine its performance metrics in a multi-reader study, and discuss the clinical implications of its specific workflow requirements. Key points DeepHealth ProstateAI is cleared as a concurrent reading aid for physicians assessing bi-parametric prostate MRIs in patients aged 40 years and older.Unlike its predicate device, it requires a separate binary mask containing the prostate gland segmentation to function.The software categorizes identified lesions into low, moderate, or high suspicion levels, which corresponded to confirmed cancer rates of 10%, 46%, and 86% in the validation cohort.Clinical testing involved a retrospective reader study where AI assistance improved the case-level detection AUC-LROC score from 0.626 to 0.724.The FDA cleared the device based on substantial equivalence to the ProstatID software, despite differences in underlying algorithms and output formats. Source: FDA 510(k) summary K253682: DeepHealth ProstateAI (Quantib) - U.S. Food and Drug Administration, 2026 This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source. Company: Quantib · Product: DeepHealth ProstateAI · FDA 510(k) K253682 Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/company-spotlight-deephealth-prostateai-standardizing-prostate-mri-det-3faaa8
- Today15 min
Why Smart MedTech Stalls in Procurement: Solving the Hospital Data Bottleneck
We unpack a 2026 Accenture report on why intelligent medical devices are struggling to scale across healthcare systems. We explore the massive disconnect between medtech's data needs and hospital IT realities, and detail the exact operational roadmap both sides need to turn fragmented data into real clinical value. Key points 97% of provider executives say privacy and security concerns are the primary barrier to sharing health data with medtech companies.Despite the push for interoperability, 73% of providers report their IT infrastructure is not prepared for future-ready data exchange.Medtech companies are rapidly diversifying their data partnerships, with a 154% increase in reliance on startups to bypass traditional hospital bottlenecks.To scale successfully, medtech must move away from bespoke, site-specific integrations and adopt enterprise-wide data standards and value-based frameworks. Source: Scaling intelligent MedTech through data synchronization - Accenture, 2026 This spot is available. Reach clinicians, health-system leaders and medtech and pharma teams following AI in medicine. Sponsor the show This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source. Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/why-smart-medtech-stalls-in-procurement-solving-the-hospital-data-bott-035187
- Yesterday14 min
Company Spotlight: Milvue TechCare Trauma - Boosting Fracture Detection by 21.8%
We unpack the FDA's 510(k) summary for Milvue's TechCare Trauma, an AI tool cleared to detect fractures and elbow joint effusions on plain X-rays. Listeners will learn how the software performs across age groups, how its high-sensitivity and high-specificity operating points work, and the results of retrospective clinical studies showing significant jumps in diagnostic sensitivity. Key points TechCare Trauma is a Class II radiological computer-assisted detection software cleared to identify fractures and elbow joint effusions across varying age groups, including neonates.In a retrospective clinical study, AI assistance improved reader sensitivity for detecting adult fractures by 21.8%, jumping from 0.807 to 0.983.The software uses two distinct operating points: a high-specificity 'YES' output (solid green line) and a high-sensitivity 'DOUBT' output (dotted white line) to manage subtle findings.Bench testing utilized massive independent datasets, including 4,109 adult and 2,872 pediatric fracture radiographs, demonstrating consistent ROC-AUC scores of 0.962 for both populations.The FDA clearance is based on substantial equivalence to a predicate device, BoneView 1.1-US, though TechCare Trauma notably excludes spine analysis. Source: FDA 510(k) summary K242171: TechCare Trauma (Milvue) - U.S. Food and Drug Administration, 2025 This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source. Company: Milvue (milvue.com) · Product: TechCare Trauma · FDA 510(k) K242171 Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/company-spotlight-milvue-techcare-trauma-boosting-fracture-detection-b-c5043f
- Yesterday17 min
Will Nurses Trust the AI? Bedside Realities and the 40% Time Savings Promise
Health systems are rushing to deploy AI tools that promise massive efficiency gains, but what happens when bedside nurses push back? This episode unpacks a comprehensive qualitative review of how frontline nurses actually experience generative AI, detailing their deep concerns about professional identity, legal liability, and the erosion of humanistic care. Key points A multicenter trial across 3 hospitals and a separate 40-nurse study show generative AI can reduce nursing documentation time by approximately 40%.Despite efficiency gains, nurses perceive multidimensional threats from AI, including functional deficits, accountability ambiguity, and the erosion of professional identity and humanistic care.Nurses' engagement with AI falls on a spectrum from a cautious wait-and-see approach to proactive integration, heavily dependent on the level of organizational readiness.The review highlights an urgent need for clinically validated, context-aware AI systems that maintain human-in-the-loop oversight.87.9% of neonatal nurses in a cited study identified professional identity as a key theme in the AI era, highlighting deep anxieties about the future of the nursing role. Source: Nurses' Attitudes and Experiences With Generative AI in Clinical Practice: Qualitative Systematic Review - Journal of medical Internet research, 2026 (CC BY) This spot is available. Reach clinicians, health-system leaders and medtech and pharma teams following AI in medicine. Sponsor the show This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source. Authors: Mengmeng Wang, Chunyan Zhang, Naikuan Ye, Huan Li, Yue Bao · DOI: 10.2196/99489 Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/will-nurses-trust-the-ai-bedside-realities-and-the-40-time-savings-pro-698069
- 2 days ago10 min
Company Spotlight: SafeBeat Rx App - AI for QT Intervals and Drug Dosing
We unpack the FDA 510(k) summary for the SafeBeat Rx App, a software tool that uses machine learning to measure ECG intervals and suggest antiarrhythmic drug dosing. We discuss its clinical testing demographics, its performance against standard databases, and the specific limitations placed on its home monitoring workflow. Key points The SafeBeat Rx App is a Software as a Medical Device (SaMD) cleared to analyze ECGs and provide provisional interval measurements like QT, QTc, and QRS.It includes an optional non-device function that suggests dosing for specific antiarrhythmic drugs like sotalol and dofetilide, based on the manufacturer's drug label.The FDA clearance relied on a primary predicate device (CardioLogs ECG Analysis Platform) and a reference device (AliveCor QT Service) to justify the use of machine learning for QT calculations.Clinical validation used a retrospective dataset with a mean age of 40.9 years, but had notable gaps in demographic data, including 16.5% unknown race or ethnicity and 36.2% unknown BMI.The FDA explicitly warns that the software workflow intended for professional healthcare environments should not be used in the home environment to adjust QT prolonging medications. Source: FDA 510(k) summary K251218: SafeBeat Rx App (SafeBeat Rx) - U.S. Food and Drug Administration, 2026 This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source. Company: SafeBeat Rx (safebeatrx.com) · Product: SafeBeat Rx App · FDA 510(k) K251218 Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/company-spotlight-safebeat-rx-app-ai-for-qt-intervals-and-drug-dosing-8e8f83
- 2 days ago16 min
Malpractice to Not Use AI? The AMA Draws a Hard Line Against Tech Giants
We unpack an urgent American Medical Association resolution pushing back against claims that unassisted clinical AI is superior to human doctors. The AMA outlines strict demands for AI liability, transparency, and a nationwide ban on non-human entities practicing medicine. Key points The AMA is pushing back on executive claims that diagnosing without AI is malpractice and that AI offers a better second opinion than doctors.A new resolution calls for model legislation to prohibit AI entities from holding professional titles or practicing medicine.The AMA demands a liability framework that protects physicians who choose not to use AI recommendations.The policy insists that developers of autonomous clinical AI must accept liability for system failure and maintain medical liability insurance.Health payors using AI for claims must ensure denials are reviewed by a physician in the exact same specialty as the treating doctor. Source: Minimizing Patient Harm from Autonomous Artificial Intelligence - American Medical Association, 2026 This spot is available. Reach clinicians, health-system leaders and medtech and pharma teams following AI in medicine. Sponsor the show This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source. Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/malpractice-to-not-use-ai-the-ama-draws-a-hard-line-against-tech-giant-1372fc
- 3 days ago18 min
When AI Saves Time, Do Doctors Just See More Patients? The AMA Battles New Burnout
The American Medical Association is pushing back against health systems using AI efficiency gains to justify higher patient quotas and shortened appointments. We unpack a 2026 resolution demanding that the cognitive work of supervising AI be recognized, and why theoretical vendor promises shouldn't dictate clinical workflows. Listeners will learn how this shapes the future of medical productivity, liability, and software purchasing. Key points Physician adoption of AI reached 81% in 2026, more than double the 38% reported in 2023.The AMA formally opposes using vendor-projected AI efficiency gains as the sole basis for shortening appointments, cutting staff, or increasing patient volume.Physicians identify administrative automation as the greatest AI opportunity (57%), while far fewer (18%) see increased physician capacity as the primary goal.Reviewing, validating, correcting, and contextualizing AI-generated clinical output must be recognized as actual work in productivity and compensation models.The AMA states that liability for system failures in autonomous clinical AI should fall to developers, and opposes non-disclosure gag clauses concerning AI flaws. Source: Ensuring Augmented Intelligence Reduces Rather Than Redistributes Physician Burden - American Medical Association, 2026 This spot is available. Reach clinicians, health-system leaders and medtech and pharma teams following AI in medicine. Sponsor the show This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source. Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/when-ai-saves-time-do-doctors-just-see-more-patients-the-ama-battles-n-d9355f
- 3 days ago12 min
Company Spotlight: Median Technologies eyonis LCS - Risk Stratifying Lung Cancer Screening
In this Company Spotlight, we dive into the FDA 510(k) clearance for Median Technologies' eyonis LCS 1.1. We unpack how this AI tool aims to go beyond basic nodule detection by assigning malignancy risk scores on low-dose chest CTs, and what the reader study numbers reveal about false positives in clinical practice. Key points Median Technologies received FDA clearance for eyonis LCS 1.1, an AI software that detects, localizes, and characterizes pulmonary nodules on low-dose Chest CT images.The software assigns a 10-point score to solid and part-solid nodules between 4-30 mm, while excluding pure ground glass and mediastinal lesions.Clearance is based on substantial equivalence to the predicate device Transpara.In a retrospective standalone study of 1,147 patients, the algorithm achieved a patient-level AUROC of 0.904.A multi-reader study of 480 patients showed aided radiologists improved their specificity to 53.59% compared to 49.45% unaided, without sacrificing sensitivity. Source: FDA 510(k) summary K251474: Median LCS (internal name) / eyonis LCS (trade name) (1.0) (Median Technologies) - U.S. Food and Drug Administration, 2026 This episode is an AI-generated conversation summarising a public document; the hosts' voices are synthetic. It is for information only and is not medical advice. Always refer to the original source. Company: Median Technologies (mediantechnologies.com) · Product: Median LCS (internal name) / eyonis LCS (trade name) (1.0) · FDA 510(k) K251474 Full transcript: https://ai-in-medicine-podcast.vercel.app/episodes/company-spotlight-median-technologies-eyonis-lcs-risk-stratifying-lung-227df8
Get AI in Medicine - curated summaries making complex issues easy to understand summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
The AI in Business Podcast
Interviews with AI executives reveal practical applications and strategic insights for business leaders adopting AI.
Me, Myself, and AI
Leaders from top companies share real-world strategies for turning artificial intelligence into measurable business results.
The Anthropic AI Daily Brief
Breaks down Anthropic's latest AI advancements and their real-world implications in clear, accessible language.
The TWIML AI Podcast (formerly This Week in Machine Learning & Artificial Intelligence)
Explores machine learning and artificial intelligence through interviews with leading researchers, engineers, and industry experts.
How I AI
A practical guide to using AI tools in work and life, featuring guests who share specific, actionable techniques and workflows.
Super Data Science: ML & AI Podcast with Jon Krohn
Conversations with data science experts exploring machine learning, AI, and real-world applications to advance technical skills and careers.
AI For Humans: Weekly AI News, Tools & Trends
A weekly breakdown of major AI news, tools, and breakthroughs for both newcomers and seasoned enthusiasts.
This Week in AI
Four AI experts analyze the latest news and trends in artificial intelligence each week.
The AI Daily Brief: Artificial Intelligence News and Analysis
A daily analysis of artificial intelligence news, exploring its creative potential, industry impacts, and ethical challenges.
Intelligent Machines (Audio)
Explores the impact of artificial intelligence through conversations with pioneers shaping the future of intelligent technology.
Global News Podcast
Global News Podcast AI
Everyday AI Podcast – An AI and ChatGPT Podcast
Covers practical uses of AI tools like ChatGPT and Midjourney to help people work more efficiently and advance their careers.
About AI in Medicine - curated summaries making complex issues easy to understand
AI in Medicine - Smart Summaries is a daily podcast for clinicians, health-system leaders and medtech, pharma and digital-health teams.Each episode unpacks one important public document on artificial intelligence in healthcare, such as FDA, EMA, MHRA, WHO or NHS guidance, OECD and World Economic Forum reports, or an open-access peer-reviewed review, in a clear 15 to 20 minute conversation.Topics include clinical AI and decision support, medical imaging and radiology AI, large language models (LLMs) and generative AI in clinical practice, AI-enabled medical devices and their regulation, the EU AI Act, drug discovery and clinical trials, digital health and wearables, health-system adoption, patient safety, bias and liability.The source of every episode is linked in the show notes, and full transcripts are at ai-in-medicine-podcast.vercel.app. The hosts' voices are AI-generated. For information only, not medical advice.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from AI in Medicine - curated summaries making complex issues easy to understand in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's AI in Medicine - curated summaries making complex issues easy to understand daily summary?
It's a free AI-powered email that summarizes new episodes of AI in Medicine - curated summaries making complex issues easy to understand as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the AI in Medicine - curated summaries making complex issues easy to understand podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official AI in Medicine - curated summaries making complex issues easy to understand product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Mike Rawson.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
What topics does AI in Medicine - curated summaries making complex issues easy to understand cover?
AI in Medicine - curated summaries making complex issues easy to understand covers topics including Science, Technology, Medicine, Fitness, Health & Fitness. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting AI in Medicine - curated summaries making complex issues easy to understand summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.